Author: Volteface Studios

This webinar recording is hosted by Katya Kowalski, Head of Operations at Volteface. The expert panel includes: Dr George Eralil, Aneeta Prem – CEO of Trigeminal Neuralgia Association, Hannah Simon – COO of Script Assist and Teri Miller a TN patient. As medical cannabis prescriptions in the UK continue to rise, more individuals diagnosed with Trigeminal Neuralgia are seeking information about whether medical cannabis could provide relief for their condition. The growing body of research on medical cannabis suggests its potential efficacy in managing various conditions, including Trigeminal Neuralgia. Studies indicate that cannabinoids, the active compounds in cannabis, possess analgesic…

Read More

As medical cannabis prescriptions in the UK continue to rise, more individuals diagnosed with Trigeminal Neuralgia are seeking information about whether medical cannabis could provide relief for their condition. The growing body of research on medical cannabis suggests its potential efficacy in managing various conditions, including Trigeminal Neuralgia. Studies indicate that cannabinoids, the active compounds in cannabis, possess analgesic and anti-inflammatory properties that may alleviate neuropathic pain associated with Trigeminal Neuralgia. For those who have not responded well to traditional pharmacological interventions, medical cannabis represents a promising alternative. Despite the increasing availability of medical cannabis prescriptions since legalization, many individuals…

Read More

How is cannabis reform progressing in Ireland? In this episode we continue to explore the state of European Cannabis reform and speak to the excellent Natalie O’Regan We cover a lot including the recent decrim bill, the Citizen’s assembly and the state of medical cannabis in Ireland. There are some very interesting similarities in terms of the challenges facing Ireland which we see elsewhere in Europe. source

Read More